Cyclosporine neurotoxicity: A review

Journal of Neurology

Volumn 246, Issue 5, 1999, Pages 339-346

  Gijtenbeek, J M M ^a,b   Van Den Bent, M J ^a   Vecht, Ch J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Cyclosporine neurotoxicity; Endothelin; Hypocholesterolemia; Hypomagnesemia; Reversible posterior leukoencephalopathy

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; ENDOTHELIN;

BRAIN DISEASE; CEREBELLUM DISEASE; CEREBRAL BLINDNESS; EXTRAPYRAMIDAL SYNDROME; HEADACHE; HUMAN; HYPERTENSION; HYPOCHOLESTEROLEMIA; HYPOMAGNESEMIA; LEUKOENCEPHALOPATHY; MENTAL DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; SEIZURE; TREMOR; VISUAL DISORDER; WHITE MATTER;

CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NERVOUS SYSTEM DISEASES; NEUROTOXINS;

EID: 0032977080     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050360     Document Type: Review

References (73)

1. 1. Appleton RE, Farrell K, Teal P, Hashimoto SA, Wong PKH (1989) Complex partial status epilepticus associated with cyclosporin A therapy. J Neurol Neurosurg Psychiatry 52:1068-1071
2. 2. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A (1984) Cyclosporine-associated central nervous system toxicity after allogenic bone marrow transplantation. Transplantation 38:34-37
3. 3. Avery R, Jabs DA, Wingard JR, Vogelsang G, Saral R, Santos G (1991) Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity. Ophthalmology 98:1294-1301
4. 4. Bartynski WS, Grabb BC, Zeigler Z, Lin L, Andrews DF (1997) Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 21:872-880
5. 5. Beaman M, Parvin S, Veitch PS, Walls J (1985) Convulsions associated with cyclosporin A in renal transplant recipients. BMJ 290:139-140
6. 6. Belli LS, De Carlis L, Romani F, Rondinara GF, Rimoldi P, Alberti A, Bettale G, Dughetti L, Ideo G, Sberna M, Belli L (1993) Dysarthria and cerebellar ataxia: late occurrence of severe neurotoxicity in a liver transplant recipient. Transpl Int 6:176-178
7. 7. Berden JHM, Hoitsma AJ, Merx JL, Keyser A (1985) Severe central-nervous-system toxicity associated with cyclosporin. Lancet 1:219-220
8. 8. Bernauer W, Gratwohl A, Keller A, Daicker B (1991) Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 115: 925-930
9. 9. Bird GLA, Meadows J, Goka J, Polson R, Williams R (1990) Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry 53:1068-1071
10. 10. Bloom ITM, Bentley FR, Garrison RN (1993) Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. Surgery 114:480-488
11. 11. Bowler JV, Peatfield RC (1992) Delusions and cyclosporine toxicity. J Neurol Neurosurg Psychiatry 55:742-743
12. 12. Deierhoi MH, Kalayoglu M, Sollinger HW, Belzer FO (1988) Cyclosporine neurotoxicity in liver transplant recipients: report of three cases. Transplant Proc 20:116-118
13. 13. Durrant S, Chipping PM, Palmer S, Gordon-Smith EC (1982) Cyclosporin A, methylprednisolone, and convulsions. Lancet 2:829-830
14. 14. Faragó M, Szabó C, Dóra E, Horváth 1, Kovách AGB (1991) Contractile and endothelium-dependent dilatory responses of cerebral arteries at various extracellular magnesium concentrations. J Cereb Blood Flow Metab 11: 161-164
15. 15. Fryer JP, Fortier MV, Metrakos P, Verran DJ, Asfar SK, Pelz DM, Wall WJ, Grand DR, Ghent CJ (1996) Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation. Transplantation 61:658-661
16. 16. Ghalie R, Fitzsimmons WE, Bennett D, Kaizer H (1990) Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant 6: 147-148
17. 17. Ghany AM, Tutschka PJ, McGhee RB, Avalos BR, Cunningham I, Kapoor N, Copelan EA (1991) Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophoshamide preparative therapy. Transplantation 52:310-315
18. 18. Gharpure VS, Hutchinson RM, Durrant STS (1989) Migraine after bone-marrow transplantation. Lancet 335:57
19. 19. Gottrand F, Largillière C, Farriaux JP (1993) Cyclosporine neurotoxicity. N Engl J Med 324:1744-1745
20. 20. Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Caereras E, Tolosa E, Rozman C (1996) Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 46:1004-1009
21. 21. Groen de PC (1988) Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 63:1012-1021
22. 22. Groen de PC (1989) Cyclosporine: a review and its specific use in liver transplantation. Mayo Clin Proc 64: 680-689
23. 23. Groen de PC, Aksamit AJ, Rakela J, Forbes GS, Krom RAF (1987) Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 317:861-866
24. 24. Guarino M, Stracciari A, Pazzaglia P, Sterzi R, Santilli I, Donato F, D'Alessandro R (1996) Neurological complications of liver transplantation. J Neurol 243:137-142
25. 25. Haug C, Duell T, Lenich A, Kolb HJ, Grünert (1995) Elevated plasma endothelin concentrations in cyclosporine-treated patients after bone marrow transplantation. Bone Marrow Transplant 16:191-194
26. 26. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494-500
27. 27. Hughes RL (1991) Cyclosporine-related central nervous system toxicity in cardiac transplantation. N Engl J Med 323:420-421
28. 28. Humphreys TR, Leyden JL (1993) Acute reversible central nervous system toxicity associated with low-dose cyclosporine therapy. J Am Acad Dermatol 29:490-492
29. 29. Jansen O, Krieger D, Krieger S, Sartor K (1996) Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy. AJNR Am J Neuroradiol 17:337-344
30. 30. Joss DV, Barrett AJ, Kendra JR, Lucas CF, Desai S (1982) Hypertension and convulsions in children receiving cyclosporin A. Lancet 1:906
31. 31. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725-1738
32. 32. Kalhs P, Brugger S, Schwarzinger I, Greinix HT, Keil F, Kyrle PA, Knöbl J, Schneider B, Höcker, Linkesch W, Lechner K (1995) Microangiopathy following allogeneic marrow transplantation. Transplantation 60:949-957
33. 33. Lane RJM, Roche SW, Leung AAW, Greco A, Lange LS (1988) Cyclosporin neurotoxicity in cardiac transplant recipients. J Neurol Neurosurg Psychiatry 51:1434-1437
34. 34. Lind MJ, Mcwilliam L, Jip J, Scarffe JH, Morgenstern GR, Chang J (1989) Cyclosporin associated demyelination following allogeneic bone marrow transplantation. Hematol Oncol 7:49-52
35. 35. Lucas MJ, Leveno KJ, Cunningham FG (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 333:201-205
36. 36. McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM, Schwartz ME, Shaw BW, So SK (1995) FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 59:530-536
37. 37. McDonald JW, Goldberg MP, Gwag BJ, Chi S, Choi DW (1996) Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol 40:750-758
38. 38. Monteiro L, Almeida-Pinto J, Rocha N, Lopes G, Rocha J (1993) Case report: cyclosporin A-induced neurotoxicity. Br J Radiol 66:271-272
39. 39. Mueller AR, Platz K-P, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus J (1994) Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 58:155-170
40. 40. Noll RB, Kulkarni R (1984) Complex visual hallucinations and cyclosporine. Arch Neurol 41:329-330
41. 41. Nozue T, Kobayashi A, Sako A, Satoh T, Kodama T, Yamazaki H, Kurosawa M, Uemasu F, Endoh H, Takagi Y (1993) Evidence that cyclosporine causes both intracellular migration and inappropriate urinary excretion of magnesium in rats. Transplantation 55: 346-349
42. 42. Nussbaum ES, Maxwell RE, Bitterman PB, Hertz MI, Bula W, Latchaw RE (1995) Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. J Neurosurg 82:1068-1071
43. 43. O'Riordan JM, FitzSimon S, O'Connor M, McCann SR (1994) Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine. Bone Marrow Transplant 13:101-104
44. 44. O'Sullivan DP (1985) Convulsions associated with cyclosporin A. BMJ 290: 858
45. 45. Pace MT, Slovis TL, Kelly JK, Abelia SD (1995) Cyclosporin A toxicity: MRI appearance of the brain. Pediatr Radiol 25:180-183
46. 46. Palmer BF, Toto RD (1991) Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am J Kidney Dis 18:116-121
47. 47. Patchell RA (1994) Neurological complications of organ transplantation. Ann Neurol 36:688-703
48. 48. Pettitt AR, Clark RE (1994) Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14:495-504
49. 49. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 63:978-983
50. 50. Platz K-P, Mueller AR, Blumhardt G, Bechstein WO, Neuhaus P (1995) Toxicity versus rejection - or why conversions between cyclosporine A and FK506 were performed after liver transplantation. Clin Transplantation 9:146-154
51. 51. Pujol A, Graus F, Rimola A, Beltrán J, Garcia-Valdecasas JC, Navasa M, Grande L, Galofré I, Visa J, Rodés J, Tolosa E (1994) Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 44: 1226-1230
52. 52. Reece DE, Frei-Lahr DA, Shepherd JD, Dorovini-Zis K, Gascoyne RD, Graeb DA, Spinelli JJ, Barnett MJ, Klingemann HG, Herzig GP, Phillips GL (1991) Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 8:393-401
53. 53. Rozen TD, Wijdicks EFM, Hay JE (1996) Treatment-refractory cyclosporine-associated headache: relief with conversion to FK-506. Neurology 47:1347
54. 54. Rubin AM, Kang H (1987) Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 37: 1072-1076
55. 55. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, Antin JH (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165: 627-631
56. 56. Small SL, Fukui MB, Bramblett GT, Eidelman BH (1996) Immunosuppression-induced leukoencephalopathy from tacrolimus (FK 506). Ann Neurol 40:575-580
57. 57. Snyder SH, Sabatini DM, Lai MM, Steiner JP, Hamilton GS, Suzdak PD (1998) Neural action of immunophilin ligands. TIPS 19:22-26
58. 58. Steg RE, Garcia EG (1991) Complex visual hallucinations and cyclosporine neurotoxicity. Neurology 41:1156
59. 59. Steiger MJ, Farrah T, Rolles K, Harvey P, Burroughs AK (1994) Cyclosporin associated headache. J Neurol Neurosurg Psychiatry 57:1258-1259
60. 60. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA (1992) Neurological complications following liver transplantation. Ann Neurol 31:644
61. 61. Thompson CB, June CH, Sullivan KM, Thomas ED (1984) Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 2:1116-1120
62. 62. Tollemar J, Ringden O, Ericzon B-G, Tyden G (1988) Cyclosporine-associated central nervous system toxicity. N Engl J Med 318:788-789
63. 63. Triverdi HS, Lal SM, Gupta N, Ross G (1996) Hypocholesterolemia is not associated with neurotoxicity in renal transplant patients. Int J Artif Organs 19:343-346
64. 64. Truwit CL, Denaro CP, Lake JR, De-Mareo T (1991) MR imaging of reversible cyclosporine A-induced neurotoxicity. AJNR Am J Neuroradiol 12: 651-659
65. 65. Valldeoriola F, Graus F, Rimola A, Andreu H, Santamaria J, Catafau A, Visa J, Tolosa E, Rodés (1996) Cyclosporine-associated mutism in liver transplant patients. Neurology 46:252-254
66. 66. Vázquez de Prada JA, Martin-Duran R, Garcia-Monco C, Calvo JR, Olalla JJ, González-Vilchez F, Gutierrez JA (1990) Cyclosporine neurotoxicity in heart transplantation. J Heart Lung Transplant 9:581-583
67. 67. Vlasveld LT, Cornelissen JJ, Dellemijn PLI, Joosse MV, van den Bent MJ (1994) Corticale blindheid tijdens behandeling met cyclosporine. Ned Tijdschr Geneeskd 138:2057-2061
68. 68. Vogt DP, Lederman RJ, Carey WD, Broughan TA (1988) Neurologic complications of liver transplantation. Transplantation 45:1057-1061
69. 69. Walker RW, Brochstein JA (1988) Neurologic complications of immunosuppressive agents. Neurol Clin 6:261-278
70. 70. Wijdicks EFM, Plevak DJ, Wiesner RH, Steers JL (1996) Causes and outcome of seizures in liver transplant recipients. Neurology 47:1523-1525
71. 71. Wijdicks EFM, Wiesner RH, Krom RAF (1995) Neurotoxicity in liver transplant recipients with cyclosporin immunosuppression. Neurology 45: 1962-1964
72. 72. Wilson SE, Groen de PC, Aksamit AJ, Wiesner RH, Garrity JA, Krom RAF (1988) Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol 8:215-220
73. 73. Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS (1995) Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 15: 247-253